TP53 and breast cancer: Our study demonstrates that a comprehensive evaluation of p53 staining patterns, rather than an arbitrary cutoff, shows a high sensitivity (96%) and specificity (100%) in predicting the presence and type of TP53 mutations in BC of NST.